Febrile Infant: Antibacterial Therapy and Empiric HSV Therapy
Initial Empirical Antibacterial Therapy for Well-Appearing Infants 7 to 60 Days Old
(These are INITIAL antimicrobial recommendations and should be re-evaluated for appropriateness at 48 hours after initiation)
Suspected Source for Infection |
8-21 Days Old |
22-28 Days Old |
29-60 Days Old |
No Focus Identified (low concern for bacterial meningitis) |
PLUS
|
|
|
UTI |
PLUS
|
|
|
Bacterial Meningitis3 |
PLUS
|
PLUS
|
PLUS
|
Empiric HSV Treatment |
|
|
|
1Alternative antibiotic (e.g. ceftazidime +/- ampicillin) must be used in neonates < 28 days old receiving concurrent calcium-containing fluids (e.g. parenteral nutrition) or known hyperbilirubinemia or jaundice.
2Gentamicin is generally not preferred at Children’s Mercy; choices should be made based on clinical factors and local susceptibility patterns.
3On the basis of CSF analysis results. Some experts will add gentamicin or another aminoglycoside to this regimen, particularly if the CSF Gram stain reveals Gram-negative organisms.
These pathways do not establish a standard of care to be followed in every case. It is recognized that each case is different, and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare a pathway for each. Accordingly, these pathways should guide care with the understanding that departures from them may be required at times.